Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Recruiting 3Active not recruiting 3Unknown 2Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 846Carcinoma, Non-Small-Cell Lung 553Neoplasms 516Prostatic Neoplasms 503Lung Neoplasms 312Colorectal Neoplasms 304Multiple Myeloma 295Neoplasm Metastasis 255Melanoma 244Ovarian Neoplasms 215Leukemia, Myeloid, Acute 212Pancreatic Neoplasms 203Squamous Cell Carcinoma of Head and Neck 171Carcinoma, Renal Cell 166Stomach Neoplasms 160Recurrence 159Lymphoma 159Carcinoma, Hepatocellular 159Glioblastoma 151Brain Neoplasms 151Lymphoma, Non-Hodgkin 143Uterine Cervical Neoplasms 142Head and Neck Neoplasms 141Urinary Bladder Neoplasms 137Leukemia, Lymphocytic, Chronic, B-Cell 137Triple Negative Breast Neoplasms 136Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Hematologic Neoplasms 117Colonic Neoplasms 117Lymphoma, Follicular 114

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Advanced Solid Cancer × Clear all
NCT05947474 2026-02-10

ORB

Orionis Biosciences Inc

Phase 1 Active not recruiting
55 enrolled

Advanced Solid Cancer

NCT04877717 2025-03-25

A Study of SHR-A1904 in Patients With Advanced Solid Cancer

Shanghai Hengrui Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
107 enrolled

Advanced Solid Cancer

NCT03791112 2025-01-27

A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor

Betta Pharmaceuticals Co., Ltd.

Phase 1 Active not recruiting
54 enrolled

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡